^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
zorpocabtagene autoleucel (MB-CART 19.1)
i
Other names: MB-CART 19.1, MB-CART19.1, Miltenyi CD-19 CAR-T cell therapy, zorpo-cel
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Miltenyi Biotec
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
